FindTrial
Sign In

A pilot study to examine the effect of vitamin C on bone turnover and antioxidant levels in postmenopausal women with low bone density - Vitamin C study

A pilot study to examine the effect of vitamin C on bone turnover and antioxidant levels in postmenopausal women with low bone density - Vitamin C study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2004-002975-17-GB
Enrollment
Unknown
Registered
2005-02-15
Start date
2005-01-31
Completion date
Unknown
Last updated
2013-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

low bone density / osteoporosis postmenopausal women

Interventions

Trade Name: Ascorbic acid tabs BP 500mg Product Name: Acorbic acid (vitamin C) Product Code: N/A Pharmaceutical Form: Tablet

Sponsors

Epsom & St Helier University Hospitals NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Post menopausal women Low bone density (T score =65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Taking drugs that affect bone metabolism Taking vitamin C supplements within the last 4 weeks Suffering from diseases (eg renal failure, rheumatoid arthritis) that can adversely affect bone density and bone metabolism

Design outcomes

Primary

MeasureTime frame
Main Objective: We want to see if vitamin C (a natural antioxidant) reduces bone turnover in women with postmenopausal osteoporosis. ;Secondary Objective: ;Primary end point(s): Changes in biochemical markers and antioxidant levels from baseline to end of study in vitamin C group group compared to controls—

Countries

United Kingdom

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026